EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment

Xin Wang iD, Jiajing Li, Alisha Biharie, Annemarie C de Vries, Marcel J C Bijvelds, Harry L A Janssen, Wenshi Wang iD, William M de Souza, Qiuwei Pan iD

mBio · 11.03.2026 · 17 (3)

DOI: 10.1128/mbio.03003-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 11.03.2026. Verfasst von Xin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Organoids, Orthobunyavirus, Bunyaviridae Infections, Interferons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oropouche virus (OROV), a neglected arbovirus, has historically been considered a self-limiting infection associated with febrile illness. However, the recent surge in cases since late 2023 has been marked by atypical outcomes, highlighting its underestimated clinical impact. Gastrointestinal symptoms such as diarrhea have also been reported, but the prevalence and mechanistic insight remain largely elusive. Here, through a meta-analysis of 12 identified clinical studies, we revealed a pooled prevalence of diarrhea as 15% (95% CI, 10%–20%) among the Oropouche patient population. In primary human intestinal organoid-based experimental models, we demonstrated productive infection by both a recent patient isolate (OROV-2024) and a historical strain (Be An19991). This is shown by the accumulation of intracellular OROV RNA, release of infectious particles, and immunostaining of OROV glycoprotein Gc. Interestingly, OROV infection mildly triggered the expression of type III interferons, but this endogenous response was insufficient to limit viral replication. In contrast, exogenous treatment with type I and III interferons strongly inhibited OROV replication, with interferon-alpha completely abolishing infectious virus production. Together, these results suggest the human intestine as a potential target organ for OROV infection and highlight interferons as potential therapeutic candidates. IMPORTANCE Oropouche virus (OROV) is an emerging arbovirus with rapidly increasing incidence and recent reports of severe disease outcomes. While gastrointestinal symptoms have been described, the intestinal tropism of OROV has not been experimentally explored. By combining meta-analysis of clinical data with human intestinal organoid infection models, we demonstrate that OROV can replicate in intestinal epithelial cells. We further show that, in a human intestinal organoid model, endogenous interferon responses are insufficient to restrict replication, while treatment with interferons exerts potent antiviral activity. These findings highlight the susceptibility of intestinal epithelial cells to OROV infection and the therapeutic potential of interferons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsOrthobunyavirusBunyaviridae InfectionsInterferonsIntestinesInterferon Type IAntiviral AgentsHumansVirus ReplicationAnimals

Stichwörter der Autor:innen

Oropouche virusinterferonsintestinal organoids

Substanzen

InterferonsInterferon Type IAntiviral Agents

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.
  • Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, China.
  • Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.

ORCID-Profile: Xin Wang, Wenshi Wang, Qiuwei Pan

Zitieren

APA

Wang, X., Li, J., Biharie, A., de Vries, A. C., Bijvelds, M. J. C., Janssen, H. L. A., Wang, W., Souza, W. M., & Pan, Q. (2026). Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment. mBio, 17(3). https://doi.org/10.1128/mbio.03003-25

Vancouver

Wang X, Li J, Biharie A, de Vries AC, Bijvelds MJC, Janssen HLA, et al. Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment. mBio. 2026;17(3). doi:10.1128/mbio.03003-25

BibTeX
@article{Wang2026,
  author = {Wang, Xin and Li, Jiajing and Biharie, Alisha and de Vries, Annemarie C and Bijvelds, Marcel J C and Janssen, Harry L A and Wang, Wenshi and Souza, William M de and Pan, Qiuwei},
  title = {Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1128/mbio.03003-25}
}
Kostenlos starten →